1,226
Views
37
CrossRef citations to date
0
Altmetric
Clinical Features - Review

Myths and misconceptions concerning contrast media-induced anaphylaxis: a narrative review

, , , &
Pages 259-266 | Received 14 Jul 2016, Accepted 11 Jan 2017, Published online: 25 Jan 2017

References

  • Brenner DJ, Hall EJ. Computed tomography-an increasing source of radiation exposure. N Engl J Med. 2007;357:2277–2284.
  • Larson D, Johnson L. National trends in CT use in the emergency department: 1995–2007. Radiology. 2011;258:164–173.
  • Katzberg RW. “Acute reactions to urographic contrast medium: incidence, clinical characteristics, and relationship to history of hypersensitivity states”–a commentary. AJR Am J Roentgenol. 2008;190(6):1431–1432.
  • American-College-of-Radiology-Committee-on-Drugs-and-Contrast-Media. ACR Manual on Contrast Media Available from: www.acr.org.
  • European-Society-of-Urogenital-Radiology. ESUR Guidelines on contrast media Available from: http://www.esur.org/
  • Canter LM. Anaphylactoid reactions to radiocontrast media. Allergy Asthma Proc. 2005;26(3):199–203.
  • Christiansen C. Late-onset allergy-like reactions to X-ray contrast media. Curr Opin Allergy Clin Immunol. 2002;2:333–339.
  • Cochran ST. Anaphylactoid reactions to radiocontrast media. Curr Allergy Asthma Rep. 2005;5(1):28–31.
  • Davis PL. Anaphylactoid reactions to the nonvascular administration of water-soluble iodinated contrast media. AJR Am J Roentgenol. 2015;204:1140–1145.
  • Dillman JR, Ellis JH, Cohan RH, et al. Allergic-like breakthrough reactions to gadolinium contrast agents after corticosteroid and antihistamine premedication. AJR Am J Roentgenol. 2008;190:187–190.
  • Fays J, Stehlin HP, Treheux A. Anaphylactoid complications of iodide contrast media in arteriography of the lower extremities during general anesthesia. Ann Anesthesiol Fr. 1976;17:105–109.
  • Lang DM, Alpern MB, Visintainer PF, et al. Elevated risk of anaphylactoid reaction from radiographic contrast media is associated with both beta-blocker exposure and cardiovascular disorders. Arch Intern Med. 1993;153:2033–2040.
  • Marik PE, Patel SY. Anaphylactoid reaction to oral contrast agent. AJR Am J Roentgenol. 1997;168:1623–1624.
  • Miller SH. Anaphylactoid reaction after oral administration of diatrizoate meglumine and diatrizoate sodium solution. AJR Am J Roentgenol. 1997;168:959–961.
  • Rose TAJ, Choi JW. Intravenous imaging contrast media complications: the basics that every clinician needs to know. Am J Med. 2015;128:943–949.
  • Katayama H, Yamaguchi K, Kozuka T, et al. Adverse reactions to ionic and nonionic contrast media. A report from the Japanese committee on the safety of contrast media. Radiology. 1990;175(3):621–628.
  • Dewachter P, Mouton-Faivre C, Felden F. Allergy and contrast media. Allergy. 2001;56:250–251.
  • Dewachter P, Mouton-Faivre C, Laroche D, et al. Immediate allergy to iodinated contrast agents and prevention of reactions. Rev Med Interne. 2009;30:872–881.
  • Dewachter P, Laroche D, Mouton-Faivre C, et al. Immediate reactions following iodinated contrast media injection: a study of 38 cases. Eur J Radiol. 2011;77:495–501.
  • Laroche D, Aimone-Gastin I, Dubois F, et al. Mechanisms of severe, immediate reactions to iodinated contrast material. Radiology. 1998;209:183–190.
  • Schiavino D, Murzilli F, Del Ninno M, et al. Demonstration of an IgE-mediated immunological pathogenesis of a severe adverse reaction to gadopentetate dimeglumine. J Investig Allergol Clin Immunol. 2003;13:140–142.
  • Tomás M, Fuentes Aparicio V, Zapatero Remon L, et al. Skin reactions to gadolinium-based contrast media. J Investig Allergol Clin Immunol. 2012;22:292–293.
  • Trcka J, Schmidt C, Seitz CS, et al. Anaphylaxis to iodinated contrast material: nonallergic hypersensitivity or IgE-mediated allergy? AJR Am J Roentgenol. 2008;190:666–670.
  • Böhm I, Schild H. Contrast medium induced anaphylaxis and prevention by selecting a compatible contrast agent. RöFo. 2008;180:1127–1129.
  • Moneret-Vautrin DA, Kanny G, Morisset M, et al. Anaphylactoid reactions and late skin reactions to iodinated contrast media: present state of the question–idea development. Rev Med Interne. 2001;22:969–977.
  • Sainte-Laudy J. Specific antibodies to iodinated contrast media. Research techniques, specificity. Allerg Immunol (Paris). 2002;34:259–260.
  • Rawlins MD, Thompson JW. Mechanisms of adverse drug reactions. In: Davies DM, Ferner RE, de Glanville H, editors. Davies’s Textbook of Adverse Drug Reactions. Oxford: Oxford University Press; 1991. p. 18–45.
  • Ryu J, Lee H, Suh J, et al. Differences between drug-induced and contrast media-induced adverse reactions based on spontaneously reported adverse drug reactions. Plos One. 2015;10:e0142418.
  • Egbert RE, De Cecco CN, Schoepf UJ, et al. Delayed adverse reactions to the parenteral administration of iodinated contrast media. AJR Am J Roentgenol. 2014;203:1163–1170.
  • Hosoya T, Yamaguchi K, Akutsu T, et al. Delayed adverse reactions to iodinated contrast media and their risk factors. Radiat Med. 2000;18(1):39–45.
  • Torres MJ, Gomez F, Dona I, et al. Diagnostic evaluation of patients with non-immediate cutaneous hypersensitivity reactions to iodinated contrast media. Allergy. 2012;67(7):929–935.
  • Torres MJ, Mayorga C, Cornejo-Garcia JA, et al. Monitoring non-immediate allergic reactions to iodine contrast media. Clin Exp Immunol. 2008;152(2):233–238.
  • Schild HH, Kuhl CK, Hübner-Steiner U, et al. Adverse events after unenhanced and monomeric and dimeric contrast-enhanced CT: a prospective randomized controlled trial. Radiology. 2006;240(1):56–64.
  • Palmiere C, Reggiani Bonetti L. Risk factors in fatal cases of anaphylaxis due to contrast media: a forensic evaluation. Int Arch Allergy Immunol. 2014;164:280–288.
  • Böhm I, Medina J, Prieto P, et al. Fixed drug eruption induced by an iodinated non-ionic X-ray contrast medium: a practical approach to identify the causative agent and to prevent its recurrence. Eur Radiol. 2007;17(2):485–489.
  • Böhm I, Schild HH. A practical guide to diagnose lesser-known immediate and delayed contrast media-induced adverse cutaneous reactions. Eur Radiol. 2006;16(7):1570–1579.
  • Bellin MF, Stacul F, Webb JA, et al. Late adverse reactions to intravascular iodine based contrast media: an update. Eur Radiol. 2011;21:2305–2310.
  • Laffitte E, Nenadov Beck M, Hofer M, et al. Severe Stevens-Johnson syndrome induced by contrast medium iopentol (Imagopaque). Br J Dermatol. 2004;150(2):376–378.
  • Schmidt BJ, Foley WD, Bohorfoush AG. Toxic epidermal necrolysis related to oral administration of diluted diatrizoate meglumine and diatrizoate sodium. AJR Am J Roentgenol. 1998;171(5):1215–1216.
  • Macías EM, Muñoz-Bellido FJ, Velasco A, et al. DRESS syndrome involving 2 unrelated substances: imipenem and iodinated contrast media. J Investig Allergol Clin Immunol. 2013;23:56–57.
  • Bircher AJ, Brockow K, Grosber M, et al. Late elicitation of maculopapular exanthemas to iodinated contrast media after first exposure. Ann Allergy Asthma Immunol. 2013;111:576–577.
  • Keller M, Lerch M, Britschgi M, et al. Processing-dependent and -independent pathways for recognition of iodinated contrast media by specific human T cells. Clin Exp Allergy. 2010;40:257–268.
  • Lerch M, Keller M, Britschgi M, et al. Cross-reactivity patterns of T cells specific for iodinated contrast media. J Allergy Clin Immunol. 2007;119(6):1529–1536.
  • Brockow K, Sánchez-Borges M. Hypersensitivity to contrast media and dyes. Immunol Allergy Clin North Am. 2014;34:547–564.
  • Mayer B, Leo A, Herziger A, et al. Intravascular immune hemolysis caused by the contrast medium iomeprol. Transfusion. 2013;53:2141–2144.
  • Bata P, Tarnoki AD, Tarnoki DL, et al. Acute severe thrombocytopenia following non-ionic low-osmolarity intravenous contrast medium injection. Korean J Radiol. 2012;13:505–509.
  • Vaillant L, Pengloan J, Blanchier D, et al. Iododerma and acute respiratory distress with leucocytoclastic vasculitis following the intravenous injection of contrast medium. Clin Exp Dermatol. 1990;15:232–233.
  • Böhm I, Schild H. Contrast-media-induced hypersensitivity or allergic/allergic-like reactions? Suggestion for a more appropriate use of the nomenclature. Eur J Clin Pharmacol. 2008;64(9):931–932.
  • Böhm I, Heverhagen JT, Klose KJ. Classification of acute and delayed contrast media-induced reactions: proposal of a three-step system. Contrast Media Mol Imaging. 2012;7(6):537–541.
  • Sesé L, Gaouar H, Autegarden JE, et al. Immediate hypersensitivity to iodinated contrast media: diagnostic accuracy of skin tests and intravenous provocation test with low dose. Clin Exp Allergy. 2016;46:472–478.
  • Brockow K, Romano A, Aberer W, et al. Skin testing in patients with hypersensitivity reactions to iodinated contrast media – a European multicenter study. Allergy. 2009;64:234–241.
  • Böhm I, Pfützner W, Klose KJ. Individual management permits contrast media enhanced CT examination without premedication. Rofo. 2012;184(12):1161–1162.
  • Hasdenteufel F, Luyasu S, Renaudin JM, et al. Anaphylactic shock after first exposure to gadoterate meglumine: two case reports documented by positive allergy assessment. J Allergy Clin Immunol. 2008;121:527–528.
  • Prieto-García A, Tomás M, Pineda R, et al. Skin test-positive immediate hypersensitivity reaction to iodinated contrast media: the role of controlled challenge testing. J Investig Allergol Clin Immunol. 2013;23:183–189.
  • Kim MH, Lee SY, Lee SE, et al. Anaphylaxis to iodinated contrast media: clinical characteristics related with development of anaphylactic shock. Plos One. 2014;9:e100154.
  • Goksel O, Aydın O, Atasoy C, et al. Hypersensitivity reactions to contrast media: prevalence, risk factors and the role of skin tests in diagnosis-a cross-sectional survey. Int Arch Allergy Immunol. 2011;155:297–305.
  • Salas M, Gomez F, Fernandez TD, et al. Diagnosis of immediate hypersensitivity reactions to radiocontrast media. Allergy. 2013;68:1203–1206.
  • Böhm I, Speck U, Schild HH. Pilot study on basophil activation induced by contrast medium. Fundam Clin Pharmacol. 2011;25(2):267–276.
  • Till G, Rother U, Gemsa D. Activation of complement by radiographic contrast media: generation of chemotactic and anaphylatoxin activities. Int Arch Allergy Appl Immunol. 1978;56:543–550.
  • Deftereos S, Giannopoulos G, Kossyvakis C, et al. Effect of radiographic contrast media on markers of complement activation and apoptosis in patients with chronic coronary artery disease undergoing coronary angiography. J Invasive Cardiol. 2009;21:473–477.
  • Böhm I, Speck U, Schild H. Non-ionic iodinated dimeric versus monomeric X-ray contrast media: effects on complement factors in vivo. RöFo. 2006;178:306–312.
  • Greenberger PA, Gutt L, Meyers SN. An immediate generalized reaction to iopamidol. Arch Intern Med. 1987;147:2208–2209.
  • Dewachter P, Tréchot P, Mouton-Faivre C. “Iodine allergy”: point of view. Ann Fr Anesth Reanim. 2005;24:40–52.
  • Dewachter P, Mouton-Faivre C. Allergy to iodinated drugs and to foods rich in iodine: iodine is not the allergenic determinant. Presse Med. 2015;44:1136–1145.
  • Baig M, Farag A, Sajid J, et al. Shellfish allergy and relation to iodinated contrast media: United Kingdom survey. World J Cardiol. 2014;6:107–111.
  • Beall JW, Mahan EF. 3rd, Blau AB. Use of amiodarone in a patient with a shellfish allergy. South Med J. 2007;100:405–406.
  • Beaty AD, Lieberman PL, Slavin RG. Seafood allergy and radiocontrast media: are physicians propagating a myth? Am J Med. 2008;121(158):e151–154.
  • Brouse SD, Phillips SM. Amiodarone use in patients with documented allergy to iodine-containing compounds. Pharmacotherapy. 2005;25:429–434.
  • Lakshmanadoss U, Lindsley J, Glick D, et al. Incidence of amiodarone hypersensitivity in patients with previous allergy to iodine or iodinated contrast agents. Pharmacotherapy. 2012;32:618–622.
  • Greenfield MF. Shellfish-iodine nexus is a myth. J Fam Pract. 2010;59:314.
  • Coakley FV, Panicek DM. Iodine allergy: an oyster without a pearl? AJR Am J Roentgenol. 1997;169:951–952.
  • Lovenstein SBR, Dweck E. Intravenous contrast and iodine allergy myth. Skinmed. 2014;12:207–208.
  • Schabelman E, Witting M. The relationship of radiocontrast, iodine, and seafood allergies: a medical myth exposed. J Emerg Med. 2010;39(5):701–707.
  • Stafford L. Hypersensitivity reaction to amiodarone in a patient with a previous reaction to an iodinated radiocontrast agent. Ann Pharmacother. 2007;41:1310–1314.
  • Castelain F, Girardin P, Moumane L, et al. Anaphylactic reaction to povidone in a skin antiseptic. Contact Dermatitis. 2016;74:55–56.
  • Böhm I, Nairz K, Morelli J, et al. Iodinated contrast media and the alleged “iodine allergy”: an inexact diagnosis leading to inferior radiologic management and adverse drug reactions. Fortschr Röntgenstr 2017; doi:10.1055/s-0042-122148
  • Zweiman B, Mishkin MM, Hildereth EA. An approach to the performance of contrast studies in contrast material-reactive persons. Ann Intern Med. 1975;83:159–162.
  • Mervak BM, Davenport MS, Ellis JH, et al. Rates of breakthrough reactions in inpatients at high risk receiving premedication before contrast-enhanced CT. AJR Am J Roentgenol. 2015;205:77–84.
  • Freed KS, Leder RA, Alexander C, et al. Breakthrough adverse reactions to low-osmolar contrast media after steroid premedication. AJR Am J Roentgenol. 2001;176:1389–1392.
  • Davenport MS, Cohan RH, Caoili EM, et al. Repeat contrast medium reactions in premedicated patients: frequency and severity. Radiology. 2009;253:372–379.
  • Charles A, Lavaud F, Gallet A, et al. Anaphylactic reaction to hydroxyzine in an anesthetized patient. Eur Ann Allergy Clin Immunol. 2009;41:120–122.
  • Lew BL, Haw CR, Lee MH. Cutaneous drug eruption from cetirizine and hydroxyzine. J Am Acad Dermatol. 2004;50:953–956.
  • Rodríguez-Jiménez B, Domínguez-Ortega J, González-García JM, et al. Dimenhydrinate-induced fixed drug eruption in a patient who tolerated other antihistamines. J Investig Allergol Clin Immunol. 2009;19:334–335.
  • Ventura MT, Calogiuri GF, Matino MG, et al. Alternative glucocorticoids for use in cases of adverse reaction to systemic glucocorticoids: a study on 10 patients. Br J Dermatol. 2003;148:139–141.
  • Danley SG. Steroid allergy? A case report and review of the literature. J Okla State Med Assoc. 2007;100:28–31.
  • Hotta E, Tamagawa-Mineoka R, Katoh N. Delayed-type hypersensitivity to 6-methyl-prednisolone sodium succinate. J Dermatol. 2014;41:754–755.
  • Sheth A, Reddymasu S, Jackson R. Worsening of asthma with systemic corticosteroids. A case report and review of literature. J Gen Intern Med. 2006;21:C11–13.
  • Schonwald S. Methylprednisolone anaphylaxis. Am J Emerg Med. 1999;17:583–585.
  • Walker AI, Räwer HC, Sieber W, et al. Immediate-type hypersensitivity to succinylated corticosteroids. Int Arch Allergy Immunol. 2011;155:86–92.
  • Chinthapalli K, Newey A, Krause M. Corticosteroid induced hyperosmolar hyperglycaemic state and hemiballismus. Oxf Med Case Reports. 2015;2015(9):320–322.
  • Liu XX, Zhu XM, Miao Q, et al. Hyperglycemia induced by glucocorticoids in nondiabetic patients: a meta-analysis. Ann Nutr Metab. 2014;65:324–332.
  • Tsuruoka S, Ioka T, Wakaumi M, et al. Severe arrhythmia as a result of the interaction of cetirizine and pilsicainide in a patient with renal insufficiency: first case presentation showing competition for excretion via renal multidrug resistance protein 1 and organic cation transporter 2. Clin Pharmacol Ther. 2006;79:389–396.
  • Shakouri AA, Bahna SL. Hypersensitivity to antihistamines. Allergy Asthma Proc. 2013;34:488–496.
  • Delgado LF, Pferferman A, Solé D, et al. Evaluation of the potential cardiotoxicity of the antihistamines terfenadine, astemizole, loratadine, and cetirizine in atopic children. Ann Allergy Asthma Immunol. 1998;80:333–337.
  • Aouam K, Bouida W, Ben Fredj N, et al. Severe ranitidine-induced anaphylaxis: a case report and literature review. J Clin Pharm Ther. 2012;37:494–496.
  • Boehm I. Is interleukin-2 therapy still a risk factor for adverse reactions in concert with iodinated contrast medium injection? Acta Radiol. 2009;50(7):752–753.
  • Zukiwski AA, David CL, Coan J, et al. Increased incidence of hypersensitivity to iodine-containing radiographic contrast media after interleukin-2 administration. Cancer. 1990;65:1521–1524.
  • Oldham RK, Brogley J, Braud E. Contrast medium “recalls” interleukin-2 toxicity. J Clin Oncol. 1990;8:942–943.
  • Carrington BM, Thomas NB, Johnson RJ. Selective splenic arteriography for interleukin-2 administration: radiologic complications from the initial 113 procedures. Eur J Radiol. 1992;14(1):13–17.
  • Abi-Aad AS, Figlin RA, Belldegrun A, et al. Metastatic renal cell cancer: interleukin-2 toxicity induced by contrast agent injection. J Immunother. 1991;10:292–295.
  • Heinzer H, Huland E, Huland H. Adverse reaction to contrast material in a patient treated with local interleukin-2. AJR Am J Roentgenol. 1992;158(6):1407.
  • Choyke PL, Miller DL, Lotze MT, et al. Delayed reactions to contrast media after interleukin-2 immunotherapy. Radiology. 1992;183:111–114.
  • Weber JCP. Epidemiology of adverse reactions to nonsteroidal anti-inflammatory drugs. In: Kd Vg R, editor. Side-effects of anti-inflammatory drugs, advances in inflammation research. New York: Raven Press; 1984. p. 1–7.
  • Morcos SK, Bellin MF, Thomsen HS, et al. Contrast Media Safety Committee of European Society of Urogenital Radiology. Reducing the risk of iodine-based and MRI contrast media administration: recommendation for a questionnaire at the time of booking. Eur J Radiol. 2008;66:225–229.
  • Brockow K, Christiansen C, Kanny G, et al. Management of hypersensitivity reactions to iodinated contrast media. Allergy. 2005;60:150–158.
  • Newmark JL, Mehra A, Singla AK. Radiocontrast media allergic reactions and interventional pain practice–a review. Pain Physician. 2012;15(5):E665–675.
  • Pasternak JJ, Williamson EE. Clinical pharmacology, uses, and adverse reactions of iodinated contrast agents: a primer for the non-radiologist. Mayo Clin Proc. 2012;87(4):390–402.
  • Singh J, Daftary A. Iodinated contrast media and their adverse reactions. J Nucl Med Technol. 2008;36:69–74.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.